Cargando…
11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway
We investigated the effect of an 11β-HSD1 inhibitor (H8) on hepatic steatosis and its mechanism of action. Although H8, a curcumin derivative, has been shown to alleviate insulin resistance, its effect on non-alcoholic fatty liver disease (NAFLD) remains unknown. Rats were fed a high-fat diet (HFD)...
Autores principales: | Chen, Ying, Li, Jiali, Zhang, Meng, Yang, Wei, Qin, Wenqi, Zheng, Qinzhou, Chu, Yanhui, Wu, Yan, Wu, Dan, Yuan, Xiaohuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182913/ https://www.ncbi.nlm.nih.gov/pubmed/35684158 http://dx.doi.org/10.3390/nu14112358 |
Ejemplares similares
-
Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
por: Anggreini, Putri, et al.
Publicado: (2022) -
Silibinin Restores NAD(+) Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver
por: Salomone, Federico, et al.
Publicado: (2017) -
Diallyl trisulfide alleviates chemotherapy sensitivity of ovarian cancer via the AMPK/SIRT1/PGC1α pathway
por: Wang, Zhaojun, et al.
Publicado: (2022) -
Knockdown of 11β-hydroxysteroid dehydrogenase type 1 alleviates LPS-induced myocardial dysfunction through the AMPK/SIRT1/PGC-1α pathway
por: Zhu, Dongmei, et al.
Publicado: (2023) -
Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK/SIRT1 Pathway
por: Wang, Yan, et al.
Publicado: (2019)